C. Chirico

Pulmonary arterial hypertension in systemic sclerosis: Diagnosis and treatment according to the European Society of Cardiology and European Respiratory Society 2015 guidelines

A. Fioravanti, R. Nuti, N. Giordano, 2018, Journal of scleroderma and related disorders.

AB0199 Serum Levels, Tissue Expression and Cellular Secretion of Macrophage Migration Inhibitory Factor (MIF) in Limited and Diffuse Systemic Sclerosis

M. Cutolo, R. Nuti, A. Magliocca, 2015 .

Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study

M. Cutolo, B. Kahaleh, R. Nuti, 2016, Arthritis Research & Therapy.

From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis

R. Nuti, S. Gonnelli, B. Lucani, 2015, International journal of immunopathology and pharmacology.

Histopathological findings in systemic sclerosis-related myopathy: fibrosis and microangiopathy with lack of cellular inflammation

M. Cutolo, R. Nuti, S. Gonnelli, 2017, Therapeutic advances in musculoskeletal disease.

Proteomic Investigation of Dermal Fibroblasts Isolated from Affected and Unaffected Skin Samples from Patients with Limited Cutaneous Systemic Sclerosis: 2 Distinct Entities?

R. Nuti, A. Santucci, R. Leoncini, 2017, The Journal of Rheumatology.

The Journal of Rheumatology Sclerosis : 2 Distinct Entities ? Unaffected Skin Samples from Patients with Limited Cutaneous Systemic Proteomic Investigation of Dermal Fibroblasts Isolated from Affected and

R. Nuti, A. Santucci, R. Leoncini, 2016 .

Pulmonary hypertension: a correct diagnosis for a suitable therapy in scleroderma patients.

A. Palazzuoli, R. Nuti, G. Ruocco, 2015, Clinical and experimental rheumatology.